APICES

What APICES does

APICES is a European clinical research organization (CRO) founded in 2009 and headquartered in Pinto (Madrid), Spain, with a second office in Paris, France. The firm delivers clinical trial services to biotechnology companies, pharmaceutical firms, medical device manufacturers, and academic/research institutions across Western, Southern, and Central Europe, operating under an ISO 9001:2015 Quality Management System with ICH-GCP, GPP, and ISO 14155:2020 compliance frameworks.

The service portfolio spans four core lines: Early Clinical Development (Phase I–IIa), Late Clinical Development (Phase III–IV), Medical Device Clinical Investigation (pre-market studies and post-market clinical follow-up under MDR), and Real-World Evidence and Health Economics & Outcomes Research (RWE/HEOR), the last of which was added through the 2023 acquisition of Kappa Sante and fully integrated by 2025. Underlying delivery is supported by clinical development services including regulatory and ethics submissions, project management, clinical monitoring, data management and biostatistics, medical writing, and clinical safety/medical monitoring, accessed by sponsors through a customer portal that includes EDC and Glass platforms.

APICES generates revenue through project-based professional services engagements originating from RFI/RFP processes, sold via a senior-led enterprise field sales model in which sponsors work directly with the execution team. The company is privately held, received strategic investment from Magnum Industrial Partners in 2021, and remains focused on European clinical trial execution with 51–100 employees.

Name

APICES

Legal name

APICES Soluciones S.L.

Website

https://apices.es

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

51–100 employees

Short description

European CRO providing project-based clinical trial execution and RWE/HEOR services to biotech, pharmaceutical, and medical device sponsors across Western, Southern, and Central Europe, with operations in Spain and France.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG)

Keywords

• Clinical research services
• Contract research organization
• Clinical trial management
• Biotech CRO services
• Medical device clinical investigation

Headquarters

HQ city

Pinto

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical Research Services: Professional services revenue generated through project-based engagements covering clinical operations, regulatory affairs, data management, biostatistics, medical writing, and safety services. Services span early clinical development through late-stage and post-approval programs across multiple therapeutic areas.
2. RWE and HEOR Services: Real-World Evidence and Health Economics & Outcomes Research services provided following the 2023 acquisition of Kappa Sante. Services include observational study design, data sourcing, analytics, and regulatory access alignment.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

APICES is a European Contract Research Organization (CRO) providing clinical research services to biotechnology, pharmaceutical, and medical device companies. The company delivers clinical trial execution across study design, regulatory submissions, clinical operations, data management, biostatistics, medical writing, and safety monitoring, covering early-phase through late-stage and post-approval programs with operations in Western, Southern, and Central Europe.

Product overview

APICES is a European CRO (Contract Research Organization) providing integrated clinical research services across biotech, pharmaceutical, and medical device sectors. The portfolio consists of four core service offerings—Early Clinical Development, Late Clinical Development, Medical Device Clinical Investigation, and RWE & HEOR Services—complemented by a comprehensive set of Clinical Development Services that span regulatory submissions, clinical monitoring, data management, biostatistics, medical writing, and safety support. All offerings are delivered through dedicated project teams supported by functional expertise across clinical operations, regulatory affairs, data management, safety, and quality. A Customer Portal with EDC and Glass platforms provides sponsors with secure access to study management tools. Services are focused on Western, Southern, and Central Europe with operations spanning Spain (HQ) and France.

Differentiator

Problem solved

Functional benefit

Brands

• Kappa Sante: RWE/HEOR specialist brand acquired by APICES in 2023, now operating under the unified APICES group

Products and services

• Clinical Development Services Comprehensive suite of clinical research services spanning study setup through execution, including clinical strategy and study design, country and site feasibility, regulatory and ethics submissions, project management and clinical operations, clinical monitoring, data management and biostatistics, medical writing, clinical safety and medical monitoring, and regulatory submission support. Designed for biotech, pharmaceutical, and medical device sponsors running European trials.
• Early Clinical Development Early phase CRO services in Europe for Phase I-IIa studies, designed to build momentum for future scale-up with focus on country and site selection based on real recruitment behavior, study designs that sites can deliver, and feasibility assumptions that do not require undoing later. Aimed at biotech and pharmaceutical sponsors moving from protocol to first European execution.
• Late Clinical Development Phase III-IV CRO services providing controlled delivery with proven governance to maintain control over timelines, quality, and data flow during late-stage studies. Emphasizes consistent execution as scale and scrutiny increase, serving pharmaceutical firms with multi-country European trials.
• Medical Device Clinical Investigation Medical device CRO services supporting pre-market studies and post-market clinical follow-up (PMCF) to generate MDR-ready evidence that withstands regulatory scrutiny. Focuses on clinical investigation plan design, execution, and documentation aligned with regulatory conclusions for medical device manufacturers.
• RWE & HEOR Services Real-World Evidence and Health Economics & Outcomes Research services including observational study design, data sourcing and governance, data management and analytics, project management, medical writing and reporting, and regulatory and access alignment. Generates evidence for market access, reimbursement, or post-approval commitments for biotech, pharmaceutical, and medical device sponsors.
• Customer Portal Secure portal providing sponsors access to customer corner, Electronic Data Capture (EDC), Glass, and other APICES platforms for study management and collaboration during clinical trial execution.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves12 records

Expansion highlights5 records

Broad incumbents

• Parexel International: Parexel is a major global full-service CRO with deep biotech and pharma sponsor relationships — a broad incumbent competitor across APICES' full clinical service portfolio.
• Charles River Laboratories: Charles River is a large incumbent providing preclinical and clinical research services including CRO offerings across multiple modalities — comparable in life sciences services breadth though anchored upstream of APICES' clinical focus.
• ICON plc: ICON is one of the world's largest global CROs offering comprehensive Phase I-IV services across all therapeutic areas — the dominant full-service incumbent APICES competes against on larger sponsor mandates.
• Medpace: Medpace is a large full-service global CRO with strong biotech focus, providing Phase I-IV clinical development services — a major incumbent competitor for biotech sponsor mandates APICES targets.
• IQVIA: IQVIA is the largest global CRO and life sciences services platform — a broad incumbent offering comprehensive clinical research services that envelop APICES' entire portfolio.

Direct peers

• Premier Research: Premier Research is a mid-tier CRO focused on biotech and specialty therapeutic areas including oncology, rare disease, and CNS — directly comparable to APICES in target customer segment and study complexity.
• Clinipace Worldwide (now Worldwide): Clinipace was a mid-market CRO focused on emerging biopharma with adaptive trial design expertise — overlapping with APICES on biotech sponsor focus, study size, and operational delivery model.
• Worldwide Clinical Trials: Worldwide is a mid-sized global CRO offering Phase I-IV clinical research, including early-phase oncology, neuroscience, and cardiometabolic — a direct competitor in the same mid-tier European CRO tier as APICES.
• Ergomed Group: Ergomed is a mid-tier global CRO with strong European presence focused on oncology and rare disease, providing Phase I-IV clinical trial services — directly comparable to APICES on size, therapeutic focus, and biotech-pharma sponsor mix.

Others

• Veeva Systems: Veeva provides cloud-based clinical trial technology platforms (EDC, CTMS, eTMF) used by CROs and sponsors — a technology ecosystem enabler used across the industry including by APICES and its peers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/apicesspain
• LinkedInlinkedin.com/company/apices-soluciones-s-l-

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about APICES